Leif Friberg

Summary

Country: Sweden

Publications

  1. ncbi Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study)
    Leif Friberg
    Karolinska Institute at South Hospital, Stockholm, Sweden
    Eur Heart J 27:1954-64. 2006
  2. ncbi Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF)
    Leif Friberg
    Department of Clinical Science and Education, Karolinska Institute at South Hospital, Stockholm, Sweden
    Eur Heart J 28:2346-53. 2007
  3. doi Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation
    Leif Friberg
    Department of Clinical Science and Education, Karolinska Institute at South Hospital, Stockholm, Sweden
    Eur Heart J 31:967-75. 2010
  4. doi The prognosis of patients with atrial fibrillation is improved when sinus rhythm is restored: report from the Stockholm Cohort of Atrial Fibrillation (SCAF)
    L Friberg
    Karolinska Institute at South Hospital, Stockholm, Sweden
    Heart 95:1000-5. 2009
  5. doi Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study
    Leif Friberg
    Department of Cardiology, Karolinska Instituet, Danderyd University Hospital, Stockholm, Sweden
    Eur Heart J 33:1500-10. 2012
  6. doi Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study
    Leif Friberg
    Karolinska Institute and Department of Cardiology, Danderyd University Hospital, Storskogsvagen 5, Bromma, Stockholm, S 16765, Sweden
    Circulation 125:2298-307. 2012
  7. doi Population screening of 75- and 76-year-old men and women for silent atrial fibrillation (STROKESTOP)
    Leif Friberg
    Department of Cardiology, Karolinska Institute, Danderyd Hospital, Stockholm, Sweden
    Europace 15:135-40. 2013
  8. pmc Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study
    Leif Friberg
    Karolinska Institute, Danderyd Hospital, Stockholm, Sweden
    BMJ 344:e3522. 2012
  9. doi High prevalence of atrial fibrillation among patients with ischemic stroke
    Leif Friberg
    From the Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden L F, M R Department of Cardiology, Danderyd Hospital, Stockholm, Sweden L F, M R Division of Neurology, Department of Clinical Sciences, Lund University, Lund, Sweden A L, B N Department of Neurology and Rehabilitation Medicine, Skane University Hospital, Lund, Sweden A L Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden A T and Riks Stroke, Medicine, Department of Public Health and Clinical Medicine, Umea University, Umea, Sweden K A
    Stroke 45:2599-605. 2014
  10. doi Association between use of β-blockers and outcomes in patients with heart failure and preserved ejection fraction
    Lars H Lund
    Unit of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden2Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden
    JAMA 312:2008-18. 2014

Detail Information

Publications11

  1. ncbi Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study)
    Leif Friberg
    Karolinska Institute at South Hospital, Stockholm, Sweden
    Eur Heart J 27:1954-64. 2006
    ..Underuse of warfarin for stroke prophylaxis in atrial fibrillation (AF) is extensive and represents a major problem in clinical practice. To identify factors associated with warfarin treatment in eligible AF patients...
  2. ncbi Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF)
    Leif Friberg
    Department of Clinical Science and Education, Karolinska Institute at South Hospital, Stockholm, Sweden
    Eur Heart J 28:2346-53. 2007
    ..Results have been conflicting in the few previously published studies. To describe mortality in patients with PxAF and to identify risk factors amenable to treatment...
  3. doi Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation
    Leif Friberg
    Department of Clinical Science and Education, Karolinska Institute at South Hospital, Stockholm, Sweden
    Eur Heart J 31:967-75. 2010
    ..The aim of this study is to investigate whether there are differences in stroke risk between PxAF and PermAF...
  4. doi The prognosis of patients with atrial fibrillation is improved when sinus rhythm is restored: report from the Stockholm Cohort of Atrial Fibrillation (SCAF)
    L Friberg
    Karolinska Institute at South Hospital, Stockholm, Sweden
    Heart 95:1000-5. 2009
    ..To what extent restoration and maintenance of sinus rhythm per se affect long-term prognosis in AF patients is less clear...
  5. doi Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study
    Leif Friberg
    Department of Cardiology, Karolinska Instituet, Danderyd University Hospital, Stockholm, Sweden
    Eur Heart J 33:1500-10. 2012
    ..Our objective was to investigate risk factors for stroke and bleeding in AF, and application of the new CHA(2)DS(2)-VASc and HAS-BLED schemes for stroke and bleeding risk assessments, respectively...
  6. doi Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study
    Leif Friberg
    Karolinska Institute and Department of Cardiology, Danderyd University Hospital, Storskogsvagen 5, Bromma, Stockholm, S 16765, Sweden
    Circulation 125:2298-307. 2012
    ..Our objective was to investigate how to maximize the likelihood of avoiding both stroke and bleeding...
  7. doi Population screening of 75- and 76-year-old men and women for silent atrial fibrillation (STROKESTOP)
    Leif Friberg
    Department of Cardiology, Karolinska Institute, Danderyd Hospital, Stockholm, Sweden
    Europace 15:135-40. 2013
    ..Secondary endpoints are: any thromboembolic event, intracranial bleeding, other major bleeding, first ever diagnosis of dementia, death from any cause, and a composite of these endpoints...
  8. pmc Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study
    Leif Friberg
    Karolinska Institute, Danderyd Hospital, Stockholm, Sweden
    BMJ 344:e3522. 2012
    ..To determine whether women with atrial fibrillation have a higher risk of stroke than men...
  9. doi High prevalence of atrial fibrillation among patients with ischemic stroke
    Leif Friberg
    From the Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden L F, M R Department of Cardiology, Danderyd Hospital, Stockholm, Sweden L F, M R Division of Neurology, Department of Clinical Sciences, Lund University, Lund, Sweden A L, B N Department of Neurology and Rehabilitation Medicine, Skane University Hospital, Lund, Sweden A L Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden A T and Riks Stroke, Medicine, Department of Public Health and Clinical Medicine, Umea University, Umea, Sweden K A
    Stroke 45:2599-605. 2014
    ..Our aim was to determine the nationwide prevalence of AF among patients with ischemic stroke, as well as their use of oral anticoagulation...
  10. doi Association between use of β-blockers and outcomes in patients with heart failure and preserved ejection fraction
    Lars H Lund
    Unit of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden2Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden
    JAMA 312:2008-18. 2014
    ..Heart failure with preserved ejection fraction (HFPEF) may be as common and may have similar mortality as heart failure with reduced ejection fraction (HFREF). β-Blockers reduce mortality in HFREF but are inadequately studied in HFPEF...
  11. doi Cardiovascular hospitalization as a surrogate endpoint for mortality in studies of atrial fibrillation: report from the Stockholm Cohort Study of Atrial Fibrillation
    Leif Friberg
    Department of Cardiology, Danderyd Hospital, Stockholm, Sweden
    Europace 13:626-33. 2011
    ..We aimed to investigate whether CV-related hospitalization is an independent risk factor and suitable as a surrogate endpoint for death in clinical studies of patients with AF...